![ISPOR 2024 May 5-8, 2024 | Atlanta, GA, USA. Early Registration Rate expires March 28.]({"type":"image" , "src" : "/sda/112343/IJME-March-May.jpg"})
Citations (47)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (6)
Johan Jendle, Åsa Ericsson, Bertil Ekman, Stefan Sjöberg, Jens Gundgaard, João da Rocha Fernandes, Ann-Charlotte Mårdby, Barnaby Hunt, Samuel J. P. Malkin & Maria Thunander. (2020) Real-world cost-effectiveness of insulin degludec in type 1 and type 2 diabetes mellitus from a Swedish 1-year and long-term perspective. Journal of Medical Economics 23:11, pages 1311-1320.
Read now
Read now
Åsa Ericsson & Adam Fridhammar. (2019) Cost-effectiveness of once-weekly semaglutide versus dulaglutide and lixisenatide in patients with type 2 diabetes with inadequate glycemic control in Sweden. Journal of Medical Economics 22:10, pages 997-1005.
Read now
Read now
Lena Landstedt-Hallin, Jens Gundgaard, Åsa Ericsson & Susanne Ellfors-Zetterlund. (2017) Cost-effectiveness of switching to insulin degludec from other basal insulins: evidence from Swedish real-world data. Current Medical Research and Opinion 33:4, pages 647-655.
Read now
Read now
Frank Lavernia, Pamela Kushner, Dace Trence, Donna Rice, George Dailey & Louis Kuritzky. (2015) Recognizing and minimizing hypoglycemia: The need for individualized care. Postgraduate Medicine 127:8, pages 801-807.
Read now
Read now
B. Peene, D. D’Hooge, T. Vandebrouck & C. Mathieu. (2014) Patient-reported frequency, awareness and patient-physician communication of hypoglycaemia in Belgium. Acta Clinica Belgica 69:6, pages 439-445.
Read now
Read now
Katarina Steen Carlsson & Ulf Persson. (2014) Cost-effectiveness of add-on treatments to metformin in a Swedish setting: liraglutide vs sulphonylurea or sitagplitin. Journal of Medical Economics 17:9, pages 658-669.
Read now
Read now
Articles from other publishers (41)
Johan Jendle, Maria Ida BuompensiereAsli Zeynep Ozdemir SaltikSimona de PortuJayne Smith-Palmer, Richard F. PollockOhad Cohen. (2023) A European Cost–Utility Analysis of the MiniMed™ 780G Advanced Hybrid Closed-Loop System Versus Intermittently Scanned Continuous Glucose Monitoring with Multiple Daily Insulin Injections in People Living with Type 1 Diabetes. Diabetes Technology & Therapeutics 25:12, pages 864-876.
Crossref
Crossref
Meryem K Talbo, Maha Lebbar, Zekai Wu, Andréane Vanasse, Marie-Laure Lalanne-Mistrih, Anne-Sophie Brazeau & Remi Rabasa-Lhoret. (2023) Gender differences in reported frequency and consequences of hypoglycemia among adults living with type 1 diabetes: Results from the BETTER registry. Diabetes Research and Clinical Practice 202, pages 110822.
Crossref
Crossref
Christina Tzogiou, Simon Wieser, Klaus Eichler, Maria Carlander, Sima Djalali, Thomas Rosemann & Michael Brändle. (2023) Incidence and costs of hypoglycemia in insulin-treated diabetes in Switzerland: A health-economic analysis. Journal of Diabetes and its Complications 37:6, pages 108476.
Crossref
Crossref
James M. Richardson & Rimma Shaginian. 2022. Basics of Hypoglycemia. Basics of Hypoglycemia.
Björn Eliasson, Åsa Ericsson, Adam Fridhammar, Andreas Nilsson, Sofie Persson & Barrie Chubb. (2022) Long-Term Cost Effectiveness of Oral Semaglutide Versus Empagliflozin and Sitagliptin for the Treatment of Type 2 Diabetes in the Swedish Setting. PharmacoEconomics - Open 6:3, pages 343-354.
Crossref
Crossref
Uffe Søholm, Melanie Broadley, Natalie Zaremba, Patrick Divilly, Giesje Nefs, Zeinab Mahmoudi, Bastiaan de Galan, Ulrik Pedersen-Bjergaard, Alan Brennan, Daniel John Pollard, Rory J McCrimmon, Stephanie A. Amiel, Christel Hendrieckx, Jane Speight, Pratik Choudhary & Frans Pouwer. (2022) Investigating the day-to-day impact of hypoglycaemia in adults with type 1 or type 2 diabetes: design and validation protocol of the Hypo-METRICS application. BMJ Open 12:2, pages e051651.
Crossref
Crossref
Johan Jendle, M. I. Buompensiere, A. L. Holm, S. de Portu, S. J. P. Malkin & O. Cohen. (2021) The Cost-Effectiveness of an Advanced Hybrid Closed-Loop System in People with Type 1 Diabetes: a Health Economic Analysis in Sweden. Diabetes Therapy 12:11, pages 2977-2991.
Crossref
Crossref
Margareta Hellgren, Ann‐Marie Svensson, Stefan Franzén, Åsa Ericsson, Soffia Gudbjörnsdottir, Nils Ekström, Rebecka Bertilsson, William Valentine & Samuel Malkin. (2021)
The burden of poor glycaemic control in people with newly diagnosed type 2 diabetes in
Sweden
: A health economic modelling analysis based on nationwide data
. Diabetes, Obesity and Metabolism 23:7, pages 1604-1613.
Crossref
Crossref
Yingqi Xu, Gabrielle Yin Yern Tong & Joyce Yu-Chia Lee. (2020) Investigation on the association between diabetes distress and productivity among patients with uncontrolled type 2 diabetes mellitus in the primary healthcare institutions. Primary Care Diabetes 14:5, pages 538-544.
Crossref
Crossref
Sam N. Scott, Michael C. Riddell & Jane E. Yardley. 2020. Endocrinology of Physical Activity and Sport. Endocrinology of Physical Activity and Sport
459
481
.
Jakob Langer, Michael L. Wolden, Seiya Shimoda, Miki Sato & Eiichi Araki. (2019) Short-Term Cost-Effectiveness of Switching to Insulin Degludec in Japanese Patients with Type 2 Diabetes Receiving Basal–Bolus Therapy. Diabetes Therapy 10:4, pages 1347-1356.
Crossref
Crossref
Simon R. Heller, J. Hans DeVries, Carol Wysham, Charlotte T. Hansen, Melissa V. Hansen & Brian M. Frier. (2019) Lower rates of hypoglycaemia in older individuals with type 2 diabetes using insulin degludec versus insulin glargine U100: Results from SWITCH 2. Diabetes, Obesity and Metabolism 21:7, pages 1634-1641.
Crossref
Crossref
Emmy De Buck, Vere Borra, Jestin N Carlson, David A Zideman, Eunice M Singletary & Therese Djärv. (2019) First aid glucose administration routes for symptomatic hypoglycaemia. Cochrane Database of Systematic Reviews 2019:4.
Crossref
Crossref
Ulrik Pedersen‐Bjergaard, Saud Alsifri, Ronnie Aronson, Maja Cigrovski Berković, Gagik Galstyan, Helge Gydesen, Jesper Barner Lekdorf, Bernhard Ludvik, Erik Moberg, Ambady Ramachandran & Kamlesh Khunti. (2019) Comparison of the HAT study, the largest global hypoglycaemia study to date, with similar large real‐world studies. Diabetes, Obesity and Metabolism 21:4, pages 844-853.
Crossref
Crossref
Emmy De Buck, Vere Borra, Jestin N Carlson, David A Zideman, Eunice M Singletary & Therese Djärv. (2019) First aid glucose administration routes for symptomatic hypoglycaemia. Cochrane Database of Systematic Reviews.
Crossref
Crossref
Johan JendleJohannes PöhlmannSimona de PortuJayne Smith-PalmerStéphane Roze. (2019) Cost-Effectiveness Analysis of the MiniMed 670G Hybrid Closed-Loop System Versus Continuous Subcutaneous Insulin Infusion for Treatment of Type 1 Diabetes. Diabetes Technology & Therapeutics 21:3, pages 110-118.
Crossref
Crossref
Giesje Nefs & François Pouwer. (2018) The role of hypoglycemia in the burden of living with diabetes among adults with diabetes and family members: results from the DAWN2 study in The Netherlands. BMC Public Health 18:1.
Crossref
Crossref
David C. Tabano, Melissa L. Anderson, Debra P. Ritzwoller, Arne Beck, Nikki Carroll, Paul A. Fishman & David C. Grossman. (2018) Estimating the Impact of Diabetes Mellitus on Worker Productivity Using Self-Report, Electronic Health Record and Human Resource Data. Journal of Occupational & Environmental Medicine 60:11, pages e569-e574.
Crossref
Crossref
Mohamed Hesham Mohamed Fahmy El Hefnawy, Talaat Abd el Fattah Abdelaaty, Atef Abdelmoniem Bassyouni, Hesham Magdeldin Saleem, Mohsen Mostafa Mussa Khalid, Dalia Nabil Toaima & Mohamed Ahmed Gaber Maree. (2018) Hypoglycemia among Insulin-treated Patients with Diabetes: Egypt Cohort of IO HAT Study. The Open Diabetes Journal 8:1, pages 34-47.
Crossref
Crossref
Pendar Farahani. (2018) Nonsevere Hypoglycemia Episode Clinical and Economic Outcomes: A Comparison between Sulfonylurea and Sodium-Glucose Cotransporter 2 Inhibitor as Add-On to Metformin from a Canadian Perspective. International Journal of Endocrinology 2018, pages 1-7.
Crossref
Crossref
Alexandria Ratzki-Leewing, Stewart B Harris, Selam Mequanint, Sonja M Reichert, Judith Belle Brown, Jason Edward Black & Bridget L Ryan. (2018) Real-world crude incidence of hypoglycemia in adults with diabetes: Results of the InHypo-DM Study, Canada. BMJ Open Diabetes Research & Care 6:1, pages e000503.
Crossref
Crossref
Ronnie Aronson, Gagik Galstyan, Margalit Goldfracht, Saud Al Sifri, Lisa Elliott & Kamlesh Khunti. (2018) Direct and indirect health economic impact of hypoglycaemia in a global population of patients with insulin-treated diabetes. Diabetes Research and Clinical Practice 138, pages 35-43.
Crossref
Crossref
Martin Haluzik, Adam Kretowski, Krzysztof Strojek, Leszek Czupryniak, Andrej Janez, Peter Kempler, Michal Andel, Tsvetalina Tankova, Mihail Boyanov, Lea Smircic Duvnjak, Laszlo Madacsy, Iwona Tarnowska, Marcin Zychma & Nebojsa Lalic. (2018) Perspectives of Patients with Insulin-Treated Type 1 and Type 2 Diabetes on Hypoglycemia: Results of the HAT Observational Study in Central and Eastern European Countries. Diabetes Therapy 9:2, pages 727-741.
Crossref
Crossref
Åsa Ericsson, Divina Glah, Maria Lorenzi, Jeroen P. Jansen & Adam Fridhammar. (2018) Cost-effectiveness of liraglutide versus lixisenatide as add-on therapies to basal insulin in type 2 diabetes. PLOS ONE 13:2, pages e0191953.
Crossref
Crossref
Johan Jendle, Åsa Ericsson, Barnaby Hunt, William J. Valentine & Richard F. Pollock. (2017) Achieving Good Glycemic Control Early After Onset of Diabetes: A Cost-Effectiveness Analysis in Patients with Type 1 Diabetes in Sweden. Diabetes Therapy 9:1, pages 87-99.
Crossref
Crossref
Sofie Persson, Gisela Dahlquist, Ulf-G. Gerdtham & Katarina Steen Carlsson. (2017) Why childhood-onset type 1 diabetes impacts labour market outcomes: a mediation analysis. Diabetologia 61:2, pages 342-353.
Crossref
Crossref
Md.Faruque Pathan, M Fariduddin, Khwaja Nazimuddin, AbdusSaleque Mollah, Md.Nazrul Islam Siddiqui, KaziAli Hassan, HS Ferdous, MuhammadHafizur Rahman, SM Ashrafuzzaman, Md.Javed Sobhan, Md.Reza E-Tanvir Haider & MohammodFeroz Amin. (2018) The incidence of hypoglycemia among insulin-treated patients with Type 1 or Type 2 diabetes: Bangladeshi cohort of international operations-hypoglycemia assessment tool study. Indian Journal of Endocrinology and Metabolism 22:3, pages 379.
Crossref
Crossref
Peter Adolfsson, Donald Rentoul, Brigitte Klinkenbijl & Christopher G Parkin. (2018) Hypoglycaemia Remains the Key Obstacle to Optimal Glycaemic Control – Continuous Glucose Monitoring is the Solution. European Endocrinology 14:2, pages 50.
Crossref
Crossref
Rifat Emral, Faruque Pathan, Carlos Augusto Yepes Cortés, M. Hesham El-Hefnawy, Su-Yen Goh, Ana Maria Gómez, Angela Murphy, Salah Abusnana, Achmad Rudijanto, Anand Jain, Zhulin Ma & Roberto Mirasol. (2017) Self-reported hypoglycemia in insulin-treated patients with diabetes: Results from an international survey on 7289 patients from nine countries. Diabetes Research and Clinical Practice 134, pages 17-28.
Crossref
Crossref
Su-Yen Goh, Zanariah Hussein & Achmad Rudijanto. (2017) Review of insulin-associated hypoglycemia and its impact on the management of diabetes in Southeast Asian countries. Journal of Diabetes Investigation 8:5, pages 635-645.
Crossref
Crossref
Jullyanna S.M. Shinosaki, Joaquim C. Rossini, Maria Luiza P.M. Jorge, Lorena B.C. Macedo & Paulo J. Tannús. (2017) Type 1 diabetes, cognition and the neurologist: Exploring Go/No‐Go and Maze tasks in the search for a practical screening tool. International Journal of Developmental Neuroscience 60:1, pages 86-93.
Crossref
Crossref
Kamlesh Khunti, Saud Alsifri, Ronnie Aronson, Maja Cigrovski Berković, Catherine Enters-Weijnen, Tom Forsén, Gagik Galstyan, Petronella Geelhoed-Duijvestijn, Margalit Goldfracht, Helge Gydesen, Rahul Kapur, Nebojsa Lalic, Bernhard Ludvik, Erik Moberg, Ulrik Pedersen-Bjergaard & Ambady Ramachandran. (2017) Impact of hypoglycaemia on patient-reported outcomes from a global, 24-country study of 27,585 people with type 1 and insulin-treated type 2 diabetes. Diabetes Research and Clinical Practice 130, pages 121-129.
Crossref
Crossref
Marc Evans, Jens Gundgaard & Brian Bekker Hansen. (2016) Cost-Effectiveness of Insulin Degludec/Insulin Aspart Versus Biphasic Insulin Aspart in Patients with Type 2 Diabetes from a Danish Health-Care Perspective. Diabetes Therapy 7:4, pages 809-823.
Crossref
Crossref
K. Khunti, S. Alsifri, R. Aronson, M. Cigrovski Berković, C. Enters‐Weijnen, T. Forsén, G. Galstyan, P. Geelhoed‐Duijvestijn, M. Goldfracht, H. Gydesen, R. Kapur, N. Lalic, B. Ludvik, E. Moberg, U. Pedersen‐Bjergaard & A. Ramachandran. (2016)
Rates and predictors of hypoglycaemia in 27 585 people from 24 countries with insulin‐treated type 1 and type 2 diabetes: the global
HAT
study
. Diabetes, Obesity and Metabolism 18:9, pages 907-915.
Crossref
Crossref
B. M. Frier, M. M. Jensen & B. D. Chubb. (2015)
Hypoglycaemia in adults with insulin‐treated diabetes in the
UK
: self‐reported frequency and effects
. Diabetic Medicine 33:8, pages 1125-1132.
Crossref
Crossref
Pavika J Lyngsie, Sandra Lopes & Jens Olsen. (2016) Incidence and cost of hypoglycemic events requiring medical assistance in a hospital setting in Denmark. Journal of Comparative Effectiveness Research 5:3, pages 239-247.
Crossref
Crossref
Lisa Elliott, Carrie Fidler, Andrea Ditchfield & Trine Stissing. (2016) Hypoglycemia Event Rates: A Comparison Between Real-World Data and Randomized Controlled Trial Populations in Insulin-Treated Diabetes. Diabetes Therapy 7:1, pages 45-60.
Crossref
Crossref
Meryl Brod, Lise Højbjerre, Donald M. Bushnell & Charlotte Thim Hansen. (2015) Assessing the impact of non-severe hypoglycemic events and treatment in adults: development of the Treatment-Related Impact Measure—Non-severe Hypoglycemic Events (TRIM-HYPO). Quality of Life Research 24:12, pages 2971-2984.
Crossref
Crossref
Clare J. Lee, Jeanne M. Clark, Michael Schweitzer, Thomas Magnuson, Kimberley Steele, Olivia Koerner & Todd T. Brown. (2015) Prevalence of and risk factors for hypoglycemic symptoms after gastric bypass and sleeve gastrectomy. Obesity 23:5, pages 1079-1084.
Crossref
Crossref
Marie Markert Jensen & Ulrik Pedersen-Bjergaard. (2015) Self-reported frequency and impact of non-severe hypoglycemic events in insulin-treated diabetic patients in Denmark. Diabetes Management 5:2, pages 67-78.
Crossref
Crossref
Raimund Weitgasser & Sandra Lopes. (2014) Self-reported frequency and impact of hypoglycaemic events in insulin-treated diabetic patients in AustriaHäufigkeit und Auswirkung von Hypoglykämien bei insulinbehandelten Diabetes-Patienten in Österreich. Wiener klinische Wochenschrift 127:1-2, pages 36-44.
Crossref
Crossref